Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

VYNEVYNE
Showing 8 of 18 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in VYNE THERAPEUTICS INC

CITADEL ADVISORS LLC holds 514,443 shares of VYNE (VYNE THERAPEUTICS INC), worth $307,380 as of 2026-Q1. The position was increased (+1585.3% shares).

Current Value

$307,380

Current Shares

514,443

Total Value Change

-$2.1M

Total Shares Change

-696,623

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
514,443
+1585.3%
$307,3800.0%$0.59
26
2025-Q4
New
30,526
-
$17,7080.0%$0.56
28
2025-Q3
Exited
0
-100.0%
$00.0%$0.33
0
2025-Q2
Decreased
1M
-5.5%
$1.7M0.0%$1.42
0
2025-Q1
Decreased
1.1M
-10.6%
$1.7M0.0%$1.70
0
2024-Q4
Increased
1.2M
+3.6%
$4.1M0.0%$3.19
28
2024-Q3
Decreased
1.2M
-1.9%
$2.2M0.0%$1.84
0
2024-Q2
Increased
1.2M
+2.5%
$2.4M0.0%$1.97
27

Other major holders of VYNE: FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used